nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—ALB—Captopril—systemic scleroderma	0.243	0.366	CbGbCtD
Gadofosveset trisodium—ALB—Mycophenolate mofetil—systemic scleroderma	0.191	0.288	CbGbCtD
Gadofosveset trisodium—ALB—Prednisone—systemic scleroderma	0.153	0.23	CbGbCtD
Gadofosveset trisodium—ALB—Methotrexate—systemic scleroderma	0.0768	0.116	CbGbCtD
Gadofosveset trisodium—Sweating increased—Prednisone—systemic scleroderma	0.000289	0.000861	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Azathioprine—systemic scleroderma	0.000288	0.000859	CcSEcCtD
Gadofosveset trisodium—Rash—Mometasone—systemic scleroderma	0.000288	0.000858	CcSEcCtD
Gadofosveset trisodium—Asthenia—Captopril—systemic scleroderma	0.000288	0.000857	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Mometasone—systemic scleroderma	0.000288	0.000857	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Leflunomide—systemic scleroderma	0.000287	0.000856	CcSEcCtD
Gadofosveset trisodium—Confusional state—Lisinopril—systemic scleroderma	0.000286	0.000853	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000286	0.000853	CcSEcCtD
Gadofosveset trisodium—Headache—Mometasone—systemic scleroderma	0.000286	0.000852	CcSEcCtD
Gadofosveset trisodium—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000851	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000285	0.00085	CcSEcCtD
Gadofosveset trisodium—Fatigue—Leflunomide—systemic scleroderma	0.000285	0.000849	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000284	0.000846	CcSEcCtD
Gadofosveset trisodium—Oedema—Lisinopril—systemic scleroderma	0.000284	0.000846	CcSEcCtD
Gadofosveset trisodium—Pruritus—Captopril—systemic scleroderma	0.000284	0.000845	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000283	0.000844	CcSEcCtD
Gadofosveset trisodium—Pain—Leflunomide—systemic scleroderma	0.000283	0.000842	CcSEcCtD
Gadofosveset trisodium—Constipation—Leflunomide—systemic scleroderma	0.000283	0.000842	CcSEcCtD
Gadofosveset trisodium—Infection—Lisinopril—systemic scleroderma	0.000282	0.000841	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000281	0.000837	CcSEcCtD
Gadofosveset trisodium—Shock—Lisinopril—systemic scleroderma	0.000279	0.000832	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000278	0.000827	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Lisinopril—systemic scleroderma	0.000277	0.000826	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Azathioprine—systemic scleroderma	0.000277	0.000824	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Azathioprine—systemic scleroderma	0.000277	0.000824	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Lisinopril—systemic scleroderma	0.000276	0.000822	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000275	0.000818	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Captopril—systemic scleroderma	0.000274	0.000817	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000274	0.000817	CcSEcCtD
Gadofosveset trisodium—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000274	0.000816	CcSEcCtD
Gadofosveset trisodium—Irritability—Methotrexate—systemic scleroderma	0.000274	0.000816	CcSEcCtD
Gadofosveset trisodium—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000815	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Leflunomide—systemic scleroderma	0.000272	0.000811	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000272	0.000811	CcSEcCtD
Gadofosveset trisodium—Fatigue—Mycophenolic acid—systemic scleroderma	0.000272	0.00081	CcSEcCtD
Gadofosveset trisodium—Nausea—Mometasone—systemic scleroderma	0.000271	0.000808	CcSEcCtD
Gadofosveset trisodium—Anorexia—Lisinopril—systemic scleroderma	0.000271	0.000807	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00027	0.000805	CcSEcCtD
Gadofosveset trisodium—Pain—Mycophenolic acid—systemic scleroderma	0.00027	0.000803	CcSEcCtD
Gadofosveset trisodium—Constipation—Mycophenolic acid—systemic scleroderma	0.00027	0.000803	CcSEcCtD
Gadofosveset trisodium—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000803	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000798	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Prednisone—systemic scleroderma	0.000268	0.000797	CcSEcCtD
Gadofosveset trisodium—Cough—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000793	CcSEcCtD
Gadofosveset trisodium—Hypotension—Lisinopril—systemic scleroderma	0.000265	0.000791	CcSEcCtD
Gadofosveset trisodium—Dizziness—Captopril—systemic scleroderma	0.000265	0.00079	CcSEcCtD
Gadofosveset trisodium—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000787	CcSEcCtD
Gadofosveset trisodium—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000784	CcSEcCtD
Gadofosveset trisodium—Urticaria—Leflunomide—systemic scleroderma	0.000263	0.000782	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Leflunomide—systemic scleroderma	0.000261	0.000778	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Leflunomide—systemic scleroderma	0.000261	0.000778	CcSEcCtD
Gadofosveset trisodium—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000261	0.000777	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00026	0.000774	CcSEcCtD
Gadofosveset trisodium—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000773	CcSEcCtD
Gadofosveset trisodium—Myocardial infarction—Prednisone—systemic scleroderma	0.000259	0.000772	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Methotrexate—systemic scleroderma	0.000259	0.000772	CcSEcCtD
Gadofosveset trisodium—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000771	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Azathioprine—systemic scleroderma	0.000258	0.000768	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000258	0.000768	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000768	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Lisinopril—systemic scleroderma	0.000255	0.00076	CcSEcCtD
Gadofosveset trisodium—Vomiting—Captopril—systemic scleroderma	0.000255	0.00076	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000756	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Lisinopril—systemic scleroderma	0.000253	0.000754	CcSEcCtD
Gadofosveset trisodium—Rash—Captopril—systemic scleroderma	0.000253	0.000753	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Captopril—systemic scleroderma	0.000253	0.000753	CcSEcCtD
Gadofosveset trisodium—Headache—Captopril—systemic scleroderma	0.000251	0.000748	CcSEcCtD
Gadofosveset trisodium—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000748	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Lisinopril—systemic scleroderma	0.00025	0.000745	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000249	0.000743	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000249	0.000743	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000741	CcSEcCtD
Gadofosveset trisodium—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000741	CcSEcCtD
Gadofosveset trisodium—Infection—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000737	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Lisinopril—systemic scleroderma	0.000247	0.000736	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000245	0.00073	CcSEcCtD
Gadofosveset trisodium—Fatigue—Lisinopril—systemic scleroderma	0.000245	0.000729	CcSEcCtD
Gadofosveset trisodium—Shock—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000729	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000727	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Leflunomide—systemic scleroderma	0.000244	0.000725	CcSEcCtD
Gadofosveset trisodium—Pain—Lisinopril—systemic scleroderma	0.000243	0.000724	CcSEcCtD
Gadofosveset trisodium—Constipation—Lisinopril—systemic scleroderma	0.000243	0.000724	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000724	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000242	0.00072	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Prednisone—systemic scleroderma	0.000242	0.00072	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000717	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Azathioprine—systemic scleroderma	0.00024	0.000713	CcSEcCtD
Gadofosveset trisodium—Nausea—Captopril—systemic scleroderma	0.000238	0.00071	CcSEcCtD
Gadofosveset trisodium—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000238	0.000708	CcSEcCtD
Gadofosveset trisodium—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000237	0.000707	CcSEcCtD
Gadofosveset trisodium—Asthenia—Leflunomide—systemic scleroderma	0.000237	0.000707	CcSEcCtD
Gadofosveset trisodium—Hallucination—Prednisone—systemic scleroderma	0.000236	0.000704	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Lisinopril—systemic scleroderma	0.000234	0.000697	CcSEcCtD
Gadofosveset trisodium—Pruritus—Leflunomide—systemic scleroderma	0.000234	0.000697	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Prednisone—systemic scleroderma	0.000233	0.000695	CcSEcCtD
Gadofosveset trisodium—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000693	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000232	0.000692	CcSEcCtD
Gadofosveset trisodium—Dizziness—Azathioprine—systemic scleroderma	0.000231	0.00069	CcSEcCtD
Gadofosveset trisodium—Asthenia—Mycophenolic acid—systemic scleroderma	0.000226	0.000674	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Leflunomide—systemic scleroderma	0.000226	0.000674	CcSEcCtD
Gadofosveset trisodium—Urticaria—Lisinopril—systemic scleroderma	0.000226	0.000672	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Lisinopril—systemic scleroderma	0.000225	0.000669	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Lisinopril—systemic scleroderma	0.000225	0.000669	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000666	CcSEcCtD
Gadofosveset trisodium—Pruritus—Mycophenolic acid—systemic scleroderma	0.000223	0.000665	CcSEcCtD
Gadofosveset trisodium—Vomiting—Azathioprine—systemic scleroderma	0.000223	0.000663	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Prednisone—systemic scleroderma	0.000222	0.000661	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000661	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Methotrexate—systemic scleroderma	0.000221	0.000658	CcSEcCtD
Gadofosveset trisodium—Infestation—Methotrexate—systemic scleroderma	0.000221	0.000658	CcSEcCtD
Gadofosveset trisodium—Rash—Azathioprine—systemic scleroderma	0.000221	0.000657	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Azathioprine—systemic scleroderma	0.000221	0.000657	CcSEcCtD
Gadofosveset trisodium—Flushing—Prednisone—systemic scleroderma	0.00022	0.000656	CcSEcCtD
Gadofosveset trisodium—Headache—Azathioprine—systemic scleroderma	0.000219	0.000653	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000653	CcSEcCtD
Gadofosveset trisodium—Dizziness—Leflunomide—systemic scleroderma	0.000219	0.000651	CcSEcCtD
Gadofosveset trisodium—Renal failure—Methotrexate—systemic scleroderma	0.000217	0.000647	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000644	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000216	0.000643	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000215	0.00064	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Prednisone—systemic scleroderma	0.000214	0.000639	CcSEcCtD
Gadofosveset trisodium—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000634	CcSEcCtD
Gadofosveset trisodium—Pain—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000634	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Prednisone—systemic scleroderma	0.000212	0.000632	CcSEcCtD
Gadofosveset trisodium—Haematuria—Methotrexate—systemic scleroderma	0.000211	0.000628	CcSEcCtD
Gadofosveset trisodium—Vomiting—Leflunomide—systemic scleroderma	0.00021	0.000626	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Lisinopril—systemic scleroderma	0.000209	0.000623	CcSEcCtD
Gadofosveset trisodium—Dizziness—Mycophenolic acid—systemic scleroderma	0.000209	0.000621	CcSEcCtD
Gadofosveset trisodium—Rash—Leflunomide—systemic scleroderma	0.000208	0.000621	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Leflunomide—systemic scleroderma	0.000208	0.00062	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Prednisone—systemic scleroderma	0.000208	0.00062	CcSEcCtD
Gadofosveset trisodium—Nausea—Azathioprine—systemic scleroderma	0.000208	0.000619	CcSEcCtD
Gadofosveset trisodium—Headache—Leflunomide—systemic scleroderma	0.000207	0.000617	CcSEcCtD
Gadofosveset trisodium—Erythema—Prednisone—systemic scleroderma	0.000207	0.000616	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Prednisone—systemic scleroderma	0.000207	0.000616	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000611	CcSEcCtD
Gadofosveset trisodium—Asthenia—Lisinopril—systemic scleroderma	0.000204	0.000607	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000606	CcSEcCtD
Gadofosveset trisodium—Pruritus—Lisinopril—systemic scleroderma	0.000201	0.000599	CcSEcCtD
Gadofosveset trisodium—Vomiting—Mycophenolic acid—systemic scleroderma	0.000201	0.000597	CcSEcCtD
Gadofosveset trisodium—Rash—Mycophenolic acid—systemic scleroderma	0.000199	0.000592	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000199	0.000592	CcSEcCtD
Gadofosveset trisodium—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000589	CcSEcCtD
Gadofosveset trisodium—Headache—Mycophenolic acid—systemic scleroderma	0.000198	0.000588	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000586	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000586	CcSEcCtD
Gadofosveset trisodium—Nausea—Leflunomide—systemic scleroderma	0.000196	0.000585	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000196	0.000584	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Prednisone—systemic scleroderma	0.000195	0.00058	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Methotrexate—systemic scleroderma	0.000195	0.000579	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Lisinopril—systemic scleroderma	0.000194	0.000579	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Methotrexate—systemic scleroderma	0.000191	0.00057	CcSEcCtD
Gadofosveset trisodium—Dizziness—Lisinopril—systemic scleroderma	0.000188	0.00056	CcSEcCtD
Gadofosveset trisodium—Nausea—Mycophenolic acid—systemic scleroderma	0.000187	0.000558	CcSEcCtD
Gadofosveset trisodium—Vertigo—Prednisone—systemic scleroderma	0.000186	0.000553	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Methotrexate—systemic scleroderma	0.000185	0.000552	CcSEcCtD
Gadofosveset trisodium—Syncope—Prednisone—systemic scleroderma	0.000185	0.000552	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Methotrexate—systemic scleroderma	0.000184	0.000549	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000546	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Prednisone—systemic scleroderma	0.000182	0.000541	CcSEcCtD
Gadofosveset trisodium—Vomiting—Lisinopril—systemic scleroderma	0.000181	0.000538	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Methotrexate—systemic scleroderma	0.000179	0.000534	CcSEcCtD
Gadofosveset trisodium—Rash—Lisinopril—systemic scleroderma	0.000179	0.000533	CcSEcCtD
Gadofosveset trisodium—Convulsion—Prednisone—systemic scleroderma	0.000179	0.000533	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Lisinopril—systemic scleroderma	0.000179	0.000533	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000179	0.000533	CcSEcCtD
Gadofosveset trisodium—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000532	CcSEcCtD
Gadofosveset trisodium—Hypertension—Prednisone—systemic scleroderma	0.000178	0.000532	CcSEcCtD
Gadofosveset trisodium—Chills—Methotrexate—systemic scleroderma	0.000178	0.00053	CcSEcCtD
Gadofosveset trisodium—Headache—Lisinopril—systemic scleroderma	0.000178	0.00053	CcSEcCtD
Gadofosveset trisodium—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000525	CcSEcCtD
Gadofosveset trisodium—Anxiety—Prednisone—systemic scleroderma	0.000175	0.000522	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000175	0.000521	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Methotrexate—systemic scleroderma	0.000174	0.000518	CcSEcCtD
Gadofosveset trisodium—Erythema—Methotrexate—systemic scleroderma	0.000173	0.000515	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Methotrexate—systemic scleroderma	0.000173	0.000515	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000507	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Methotrexate—systemic scleroderma	0.000169	0.000504	CcSEcCtD
Gadofosveset trisodium—Nausea—Lisinopril—systemic scleroderma	0.000169	0.000503	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Prednisone—systemic scleroderma	0.000169	0.000503	CcSEcCtD
Gadofosveset trisodium—Oedema—Prednisone—systemic scleroderma	0.000169	0.000503	CcSEcCtD
Gadofosveset trisodium—Infection—Prednisone—systemic scleroderma	0.000168	0.000499	CcSEcCtD
Gadofosveset trisodium—Shock—Prednisone—systemic scleroderma	0.000166	0.000494	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Prednisone—systemic scleroderma	0.000165	0.000493	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Prednisone—systemic scleroderma	0.000165	0.00049	CcSEcCtD
Gadofosveset trisodium—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000165	0.00049	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Prednisone—systemic scleroderma	0.000164	0.000488	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Prednisone—systemic scleroderma	0.000163	0.000486	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Methotrexate—systemic scleroderma	0.000163	0.000485	CcSEcCtD
Gadofosveset trisodium—Anorexia—Prednisone—systemic scleroderma	0.000161	0.000479	CcSEcCtD
Gadofosveset trisodium—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000471	CcSEcCtD
Gadofosveset trisodium—Rash—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000467	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000467	CcSEcCtD
Gadofosveset trisodium—Headache—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000464	CcSEcCtD
Gadofosveset trisodium—Vertigo—Methotrexate—systemic scleroderma	0.000155	0.000462	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Prednisone—systemic scleroderma	0.000151	0.000451	CcSEcCtD
Gadofosveset trisodium—Cough—Methotrexate—systemic scleroderma	0.000151	0.000449	CcSEcCtD
Gadofosveset trisodium—Convulsion—Methotrexate—systemic scleroderma	0.00015	0.000446	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Prednisone—systemic scleroderma	0.000149	0.000442	CcSEcCtD
Gadofosveset trisodium—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000148	0.00044	CcSEcCtD
Gadofosveset trisodium—Chest pain—Methotrexate—systemic scleroderma	0.000147	0.000438	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Prednisone—systemic scleroderma	0.000147	0.000437	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000146	0.000435	CcSEcCtD
Gadofosveset trisodium—Fatigue—Prednisone—systemic scleroderma	0.000145	0.000433	CcSEcCtD
Gadofosveset trisodium—Constipation—Prednisone—systemic scleroderma	0.000144	0.00043	CcSEcCtD
Gadofosveset trisodium—Confusional state—Methotrexate—systemic scleroderma	0.000142	0.000423	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000141	0.00042	CcSEcCtD
Gadofosveset trisodium—Infection—Methotrexate—systemic scleroderma	0.00014	0.000417	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Prednisone—systemic scleroderma	0.000139	0.000414	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Methotrexate—systemic scleroderma	0.000138	0.000412	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000138	0.000411	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Methotrexate—systemic scleroderma	0.000137	0.000408	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000136	0.000406	CcSEcCtD
Gadofosveset trisodium—Anorexia—Methotrexate—systemic scleroderma	0.000134	0.0004	CcSEcCtD
Gadofosveset trisodium—Urticaria—Prednisone—systemic scleroderma	0.000134	0.000399	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Prednisone—systemic scleroderma	0.000133	0.000397	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Prednisone—systemic scleroderma	0.000133	0.000397	CcSEcCtD
Gadofosveset trisodium—Hypotension—Methotrexate—systemic scleroderma	0.000132	0.000392	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Methotrexate—systemic scleroderma	0.000127	0.000377	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Methotrexate—systemic scleroderma	0.000126	0.000374	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Prednisone—systemic scleroderma	0.000124	0.00037	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Methotrexate—systemic scleroderma	0.000124	0.00037	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Methotrexate—systemic scleroderma	0.000123	0.000365	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000122	0.000363	CcSEcCtD
Gadofosveset trisodium—Fatigue—Methotrexate—systemic scleroderma	0.000122	0.000362	CcSEcCtD
Gadofosveset trisodium—Asthenia—Prednisone—systemic scleroderma	0.000121	0.000361	CcSEcCtD
Gadofosveset trisodium—Pain—Methotrexate—systemic scleroderma	0.000121	0.000359	CcSEcCtD
Gadofosveset trisodium—Pruritus—Prednisone—systemic scleroderma	0.000119	0.000356	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Methotrexate—systemic scleroderma	0.000116	0.000346	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Prednisone—systemic scleroderma	0.000115	0.000344	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000115	0.000343	CcSEcCtD
Gadofosveset trisodium—Urticaria—Methotrexate—systemic scleroderma	0.000112	0.000334	CcSEcCtD
Gadofosveset trisodium—Dizziness—Prednisone—systemic scleroderma	0.000112	0.000332	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Methotrexate—systemic scleroderma	0.000111	0.000332	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Methotrexate—systemic scleroderma	0.000111	0.000332	CcSEcCtD
Gadofosveset trisodium—Vomiting—Prednisone—systemic scleroderma	0.000107	0.00032	CcSEcCtD
Gadofosveset trisodium—Rash—Prednisone—systemic scleroderma	0.000106	0.000317	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Prednisone—systemic scleroderma	0.000106	0.000317	CcSEcCtD
Gadofosveset trisodium—Headache—Prednisone—systemic scleroderma	0.000106	0.000315	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Methotrexate—systemic scleroderma	0.000104	0.000309	CcSEcCtD
Gadofosveset trisodium—Asthenia—Methotrexate—systemic scleroderma	0.000101	0.000301	CcSEcCtD
Gadofosveset trisodium—Nausea—Prednisone—systemic scleroderma	0.0001	0.000298	CcSEcCtD
Gadofosveset trisodium—Pruritus—Methotrexate—systemic scleroderma	9.98e-05	0.000297	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Methotrexate—systemic scleroderma	9.65e-05	0.000287	CcSEcCtD
Gadofosveset trisodium—Dizziness—Methotrexate—systemic scleroderma	9.32e-05	0.000278	CcSEcCtD
Gadofosveset trisodium—Vomiting—Methotrexate—systemic scleroderma	8.96e-05	0.000267	CcSEcCtD
Gadofosveset trisodium—Rash—Methotrexate—systemic scleroderma	8.89e-05	0.000265	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Methotrexate—systemic scleroderma	8.88e-05	0.000265	CcSEcCtD
Gadofosveset trisodium—Headache—Methotrexate—systemic scleroderma	8.83e-05	0.000263	CcSEcCtD
Gadofosveset trisodium—Nausea—Methotrexate—systemic scleroderma	8.38e-05	0.000249	CcSEcCtD
